Biosimilar drugs could save up to €98bn by 2020, says IMS
But savings from lower-cost copies depend on doctor education, healthcare provider strategies
But savings from lower-cost copies depend on doctor education, healthcare provider strategies
Shire said previous £46.26 cash-and-stock proposal undervalued the pharma company
Irish-domiciled Shire viewed as prime takeover target for US pharmaceutical giants
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Read the digital edition of The Gloss magazine now
Weddings, Births, Deaths and other family notices